$22.43-0.46 (-2.01%)
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States.
Tactile Systems Technology, Inc. in the Healthcare sector is trading at $22.43. The stock is currently 41% below its 52-week high of $37.77, remaining 2.6% above its 200-day moving average. Technical signals show neutral RSI of 31 and bearish MACD signal, explaining why TCMD maintains its current momentum and trend strength. The Whystock Score of 75/100 reflects a high-conviction bullish alignment.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of ly...
Tactile Systems Technology (NASDAQ:TCMD) reported first-quarter 2026 revenue of $75.3 million, up 23% year-over-year, as management pointed to “focused execution” on strategic priorities, continued commercial momentum, and operational changes made ahead of Medicare’s new prior authorization requirem
Welcome, ladies and gentlemen, to the First Quarter 2026 Earnings Call for Tactile Systems Technology, Inc. At this time, all participants have been placed in a listen-only mode. With me from Tactile Systems Technology, Inc.’s management team are Sheri Louise Dodd, Chief Executive, and Elaine M. Birkemeyer, Chief Financial Officer.
Tactile Systems Technology (TCMD) delivered earnings and revenue surprises of -9.14% and +5.88%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Here with me is Elaine Birkemeyer, our Chief Financial Officer. By business line, lymphedema revenue increased 2% year-over-year to $66 million and airway clearance revenue increased 51.6% year-over-year to $12.9 million.
This call will also include references to certain financial measures that are not calculated in accordance with Generally Accepted Accounting Principles or GAAP. Reconciliations of those non-GAAP financial measures to the most comparable measures calculated and presented in accordance with GAAP are available in the earnings press release on the Investor Relations portion of our website.